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Background: Cardiac fibrosis disrupts the normal myocardial structure and has a direct impact on heart function
and survival. Despite already available digital methods, the pathologist’s visual score is still widely considered as
ground truth and used as a primary method in histomorphometric evaluations. The aim of this study was to
compare the accuracy of digital image analysis tools and the pathologist’s visual scoring for evaluating fibrosis in
human myocardial biopsies, based on reference data obtained by point counting performed on the same images.
Methods: Endomyocardial biopsy material from 38 patients diagnosed with inflammatory dilated cardiomyopathy
was used. The extent of total cardiac fibrosis was assessed by image analysis on Masson’s trichrome-stained tissue
specimens using automated Colocalization and Genie software, by Stereology grid count and manually by
Pathologist’s visual score.
Results: A total of 116 slides were analyzed. The mean results obtained by the Colocalization software (13.72 ±
12.24%) were closest to the reference value of stereology (RVS), while the Genie software and Pathologist score
gave a slight underestimation. RVS values correlated strongly with values obtained using the Colocalization and
Genie (r > 0.9, p < 0.001) software as well as the pathologist visual score. Differences in fibrosis quantification by
Colocalization and RVS were statistically insignificant. However, significant bias was found in the results obtained by
using Genie versus RVS and pathologist score versus RVS with mean difference values of: −1.61% and 2.24%.
Bland-Altman plots showed a bidirectional bias dependent on the magnitude of the measurement: Colocalization
software overestimated the area fraction of fibrosis in the lower end, and underestimated in the higher end of the
RVS values. Meanwhile, Genie software as well as the pathologist score showed more uniform results throughout
the values, with a slight underestimation in the mid-range for both.
Conclusion: Both applied digital image analysis methods revealed almost perfect correlation with the criterion
standard obtained by stereology grid count and, in terms of accuracy, outperformed the pathologist’s visual score.
Genie algorithm proved to be the method of choice with the only drawback of a slight underestimation bias,
which is considered acceptable for both clinical and research evaluations.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/9857909611227193
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Cardiac fibrosis is associated with disruption of the normal
myocardial structure by excessive deposition of extracellular
matrix. The term fibrosis encompasses several processes
including fibroblast proliferation, collagen synthesis and
degradation, as well as conversion of fibroblasts into a con-
tractile “myofibroblast” phenotype. Myocardial matrix re-
modeling and fibrosis appear to play a pivotal role in the
development of ventricular dilatation and heart failure [1].
The net effect of cardiac fibrosis is exaggerated by the in-
creased tissue stiffness, impaired contraction due to myocyte
slippage (separation), disrupted electrotonic connectivity
and tissue hypoxia [2]. For these reasons, it is particularly
important to understand cardiac fibrosis as the mechanistic
basis of cardiac remodeling. It is well known, that fibrosis
and certain histological changes in the myocardium impact
heart function and even survival [3,4].
Evaluation of the extent of fibrosis, including semi-
automated and semi-quantitative methods has been intro-
duced earlier, however, detailed literature on methodo-
logical and technical aspects of quantification of fibrosis is
scarce [5]. Most previous studies explored liver and kidney
fibrosis [6-10], but up to now only a few have attempted
to automatically quantify cardiac fibrosis [11-17]. Another
limitation of recent publications is that the evaluations of
cardiac fibrosis mostly have been done on animal models
(mice, rats, dogs, pigs) and only few studies are on human
hearts [18,19]. Moreover, the majority of such studies lack
data validation to an appropriate criterion standard and
the reference values are obtained by semi-quantitative vis-
ual evaluations rather than by more direct quantitative
estimates.
Significant drift towards automation and quantification
in pathology has occurred during the last decade [20-22].
Digital imaging in pathology provides users with similar
functionalities of a microscope, but with numerous add-
itional benefits and consequently, replaces subjective visual
evaluation by presumably more objective and reproducible
digital analyses [23-26]. Several applications of image ana-
lysis have recently received clearance from US Food and
Drug Administration, indicating that automated quantifi-
cation may provide more reliable and reproducible results
than visual evaluation [20,27]. Numerous recent studies
show that advanced computer image analyses can be
successfully introduced in clinical practice and research
[28-30]. Meanwhile, the interpretation of histomorpho-
metric parameters in clinical routine and research is still
primarily based on human visual scoring, which is hugely
subjective [25,26]. Many factors affect human vision in-
cluding: contrast, borders and color – all these impacts
may be easily illustrated using a number of optical illu-
sions. Semi-quantitative scoring not only involves a sub-
stantial workload on a pathologist, but also has several
limitations inherent to the traditional pathology, such assignificant intra- and inter-observer variation along with
low efficiency [31].
Segmentation of stained tissue images is a complex
problem, because of a large variability of the tissue sam-
ples (shape, size, color and architecture) [32]. Growing
numbers of virtual slides that must be processed, trans-
mitted and analyzed create a clear need of additional
image correction and standardization algorithms [33].
Automatic selection of slides, application of appropriate
thresholds and also a reliable selection of the slide areas
containing the most significant information (regions of
interest (ROI)) to deriving the diagnosis is becoming of
major importance in virtual pathology [34]. Only a
complete set of these computerized algorithms can even-
tually replace the pathologist’s unique work [22,35].
The most common practice of implementing a new
digital algorithm is to compare the results obtained with
the pathologist’s visual evaluation, that is, to validate it
against the best clinically accepted method. This percep-
tion, however, is no longer valid: why should one calibrate
a potentially more accurate and precise tool against a vari-
able and semi-quantitative evaluation method? To esti-
mate the accuracy of a new method, a criterion standard
has to be obtained from an independent source measured
in the most possible objective way. In this regard, stereol-
ogy grid count, rather than the pathologist’s visual impres-
sion should be used [36-38]. Therefore, we performed our
study on evaluating the accuracy of digital image analysis
tools and the pathologist’s visual scoring for the measure-
ment of fibrosis extent (ie: area fraction) in human myo-
cardial biopsies, based on reference data obtained by point
counting performed on the same images.
Methods
Experimental model
The study was conducted on endomyocardial biopsy
(EMB) material from 38 patients (29 males, 9 females,
mean age 42.3 ± 12.2 years) diagnosed with inflammatory
dilated cardiomyopathy. All EMB specimens were col-
lected between July, 2010 and February, 2013. Before
EMB, each patient underwent coronary angiography to
exclude coronary artery disease. Right ventricular EMB
was obtained using a flexible bioptome via the right fem-
oral vein [39]. At least 3 EMBs were subjected to histo-
logical evaluation. All specimens were included in the
study to provide a full range of fibrosis.
Tissue samples for histological analysis were fixed in 10%
neutral buffered formalin with subsequent routine paraffin
embedding. 3 μm-thick sections were used through the
study. Sections were stained with Masson’s trichrome ac-
cording to a standard protocol. Whole slide images (WSI)
from the experimental glass slides were obtained at a
resolution of 0.5 μm using a digital microscopic scanner
(ScanScope® XT, Aperio Technologies, Vista, CA, USA) at a
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on a devoted WSI server (Spectrum 11.1.0.751, Aperio)
(Figure 1A). One section was later randomly chosen from
the slide for all subsequent analyses. Aperio Colocalization
and Genie algorithms were used for image analysis.
Colocalization algorithm
Colocalization uses the color deconvolution [40] to separ-
ate the stains and classifies each pixel according to theC
B
A
Figure 1 Fibrosis mark-up on digitized slide: (A) Masson trichrome ornumber of stains present. For Colocalization, the threshold
for each stain is specified for a required stain (e.g. Masson’s
trichrome) and the algorithm reports the percentage of
total tissue area for which each stain combination is de-
tected: 1, 2, 3, 1 + 2, 1 + 3, 2 + 3, 1 + 2 + 3, or none (up to 3
stains are supported). The algorithm also provides an
eight-color mark-up image for the visualization of the
colocalized stains. The total percentage of cardiac fibro-
sis in biopsy samples was calculated according to theiginal staining, (B) Colocalization algorithm, (C) Genie algorithm.
AB
Daunoravicius et al. Diagnostic Pathology 2014, 9:114 Page 4 of 10
http://www.diagnosticpathology.org/content/9/1/114sums of the following stain combinations: 3, 2 + 3 and 1 +
3 (Figure 1B).
Genie algorithm
Genie (GENetic Imagery Exploration [41]) is a pattern rec-
ognition algorithm that distinguishes spatial and morpho-
logical features based on structures (classes) provided by
the user. A specific Genie classifier was developed as fol-
lows: 1. New Genie project and training set created; 2.
Digital slides added to a training set; 3. The classes of
interest defined and marked in the digital slides in the
training set (Figure 2A); 4. Training montage created by
running Genie Training v1 algorithm (1000 training itera-
tions set) on user-selected tissue sub-regions (the algo-
rithm estimated the training accuracy at 99.4%); 5. Based
on the training macro, Genie Classifier v1 algorithm was
used to create the specific Classifier to be tested and used
(Figure 2B). After testing the classifier the classes can then
be selected for subsequent analysis using specific task al-
gorithms. For better identification of cardiac fibrosis, we
used only spatial recognition, disabling the detection of
morphological features. For this study, the Genie system
was trained to distinguish the myocardium, fibrous tissue
(fibrosis) and glass (Figure 2B). Total cardiac fibrosis per-
centage was adjusted to a total tissue area in the image an-
alyzed, ignoring the glass (Figure 1C).
Stereology
Stereology is an interdisciplinary field for volume esti-
mation of three-dimensional structures by their planar
sections. We performed our study on tissue sections ofA
B
Figure 2 Training and using of the genie: (A) Defining and
marking the classes of interest, (B) Testing and using the new
specific classifier.3 μm, thus the stereology was performed on a projection
rather than on ideal 2D plane. A point counting grid was
used to estimate the fraction area [42]. “Stereology toolkit
4.2.0” from ADCIS (Saint Contest, France) was used in
this study. This stereology module allows defining a ROI
and a grid that overlay an area of a virtual slide. Then the
type, the spacing and the pattern size of the grid must be
adjusted (Figure 3A). 150–200 test points are recom-
mended for acceptable analysis precision [43,44]. The grid
of point counting, with the sampling interval of 200 pixels
and a pattern size of 20 pixels was chosen to evaluate the
area fraction of myocardial tissue and cardiac fibrosis.
These adjustments of the stereology grid ensured a mini-
mum of 500 test points in the smallest myocardial biopsies
and higher counting precision. The structures of interest:
glass, fibrosis, myocardium, other (including inflammation,C
Figure 3 Fibrosis mark-up on digitized slide using stereology
protocol: (A) ImageScope V11 view incorporating grid
(sampling step 200 pixels and size of the pattern 20 pixels),
(B, C) structures of interest (glass, fibrosis, myocardium, other)
manually highlighted by observer.
Table 1 Summary statistics for cardiac fibrosis (%) evaluation methods
Stereology Colocalization Genie Pathologist week 0 Pathologist week 2
Number of observations 116 116 116 116 116
Mean 13.21 13.72 11.60 11.20 10.76
Median 8.70 11.12 7.39 5.00 5.00
Std. deviation 15.25 12.24 15.41 15.53 17.37
Range 96.50 73.79 88.22 100.00 100.00
Minimum 0.00 1.57 0.05 0.00 0.00
Maximum 96.50 75.36 88.27 100.00 100.00
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highlighted by the observer (Figure 3B, C). The total per-
centage of cardiac fibrosis was counted using the number
of points ignoring the “glass” and “other” category. The area
fraction, equivalent to the volume fraction of cardiac fibro-
sis was then estimated as the ratio between the number of
test marked as fibrosis and the total number of test points
included in the ROI, points ignoring the “glass” and “other”
categories. The results were expressed as percentages to-
gether with the corresponding uncertainty computed ac-
cording to Weibel [43].Pathologist’s visual scoring
The extent of total cardiac fibrosis in the samples was
also evaluated as a percentage of the sample area by a
highly-experienced pathologist using a light microscope.
Two evaluations were performed with the time interval
of two weeks.Table 2 Pairwise correlations between stereology, digital
algorithms and pathologist score (Pearson’s coefficients,
p < 0.001, N = 116)Statistical analysis
Data are presented as means and standard deviation
(Mean ± std. deviation). For the statistical comparison of
data, the Pearson’s correlation coefficient, Friedman’s test
with post hoc (Wilcoxon signed-rank with a Bonferroni
correction applied) and scatter-dot graphs (with r2, inter-
cept and slope) were used. To enable a standard approach
to the data, a natural logarithmic transformation of all
measurements was performed before drawing scatted-dot
plots. The agreement between fibrosis measurement
methods was tested with Bland-Altman plots [45], using
the stereology estimation as a reference method for the X
axis [46]. All statistical analysis was performed using
the SPSS package (version 19.0 for Windows; SPSS Inc.,




Pathologist week 0 0.913 0.839 0.841
Pathologist week 2 0.929 0.853 0.856 0.965Ethical approval
The study was approved by the Vilnius Regional Biomed-
ical Research Ethics committee Nr.158200-09-382-103. All
patients gave written informed consent to include their
data in the study for each investigational procedure.Results
A total of 116 slides were analyzed digitally, by visual
scoring and using stereology grids.
The mean result of fibrosis obtained by Colocalization
software was 13.72 ± 12.24% being closest to the reference
value of stereology (RVS: 13.21 ± 15.25%). The mean
values obtained by the Genie software (11.60 ± 15.41%)
and the pathologist’s score at week 0 (11.20 ± 15.53%) and
week 2 (10.76 ± 17.37%) indicated a slight underestimation
relative to RVS. However, the range of Colocalization soft-
ware was 73.79% being the lowest of all tested methods
with a difference of around 20%. The range of the Genie
software was 88.22% and the pathologist’s score had the
highest range of 100%. These results were comparable to
the range of the RVS (96.50%), Table 1.
Both the Colocalization and Genie methods correlated
very strongly with the RVS cardiac fibrosis estimates,
yielding r = 0.928 and r = 0.946 (p < 0.001), respectively.
Similarly, the pathologist’s visual score strongly corre-
lated with RVS: r = 0.913 (p < 0.001) at week 0 and r =
0.929 (p < 0.001) at week 2 (Table 2).
Friedman’s test revealed statistically significant differ-
ences in the results of tested cardiac fibrosis evaluation
methods χ2(3) = 62.405, p = 0.000. Post hoc analysis with
Wilcoxon signed-rank tests with a Bonferroni correction
(significance level set at p < 0.0125) was applied. The dif-
ferences in the results of Colocalization versus RVS were
statistically insignificant (Z = −2.259, p = 0.024) with a
mean difference value of 0.50%. However, post hoc ana-
lysis showed significant differences between the results
of Genie versus RVS (Z = −5.000, p = 0.000) and the
Table 3 Paired comparison of cardiac fibrosis (%) evaluation methods
Paired differences Z* p value*
Mean Std. Deviation
Pair 1 Colocalization – Stereology 0.50 6.00 −2.259 0.024
Pair 2 Genie – Stereology −1.61 5.02 −5.000 0.000
Pair 3 Pathologist mean – Stereology 2.24 6.01 −4.422 0.000
Pair 4 Colocalization – Genie 2.11 4.49 −6.639 0.000
* Based on post hoc analysis with Wilcoxon signed-rank tests (Bonferroni correction applied with significance level set at p < 0.0125).
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0.000) with mean difference values of: −1.61% and 2.24%.
Similarly significant difference of the results between
both digital methods (Genie versus Colocalization) was
noted: Z =−6.639, p = 0.000 with a variance bias of 2.11%
(Table 3).
Single linear regression model plots demonstrated
some advantage of Genie software over the Colocali-
zation software with noticeably better values in both
original raw and log-transformed measurements for r-
square 0.896 and 0.804 (log) versus 0.861 and 0.707
(log); slope 0.956 and 1.222 (log) versus 0.745 and 0.639
(log); intercept −1.033 and −0.860 (log) versus 3.875
and 0.972 (log) (Figure 4). The pathologist’s mean score
correlation with RVS was similar: r-square 0.864 and
0.684 (log), slope 0.994 and 0.838 (log), intercept −2.155






Figure 4 Single linear regression models with reference values: (A) co
Linear regression line is presented within 95% confidence interval.and week 2 was negligible: r-square 0.931 and 0.824 (log),
slope 1.079 and 0.939 (log), intercept −1.328 and −0.020
(log). Surprisingly, both digital methods did not correlate
as well as expected with still acceptable r-square values
(0.947 and 0.794 (log)), but high intercept (4.744 and
1.500 (log)) and slope far from ideal (0.773 and 0.486
(log)) (Figure 5).
Bland-Altman plots showed a bidirectional bias
dependent on the magnitude of the measurement: Coloca-
lization software overestimated the area fraction of fibrosis
in the lower end, and underestimated it in the higher end
of the RVS scale (Figure 6A). Meanwhile, Genie software
as well as the pathologist’s mean score showed more uni-
form results throughout the complete scale with a slight
underestimation in the mid-range for both (Figure 6B, C).
Presented histograms indicate a normal distribution of the



















Figure 5 Single linear regression models with reference values: (A) Pathologist mean score and stereology; (B) pathologist score at
week 0 and week 2; (C) colocalization and genie. Linear regression line is presented within 95% confidence interval.
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To this day a pathologist’s visual score is widely accepted
as ground truth and, despite already available digital
methods, it is still used as a primary method for histo-
morphometric evaluations. Many attempts to incorpor-
ate digital methods into clinical practice face the same
issue of proper validation – the digital analysis data are
commonly compared to semi-quantitative visual evalu-
ation, while most direct criterion standard yet requires
time-consuming procedures.
The early study of Vasiljevic et al. [13] based on hu-
man endomyocardial biopsies compared results of semi-
quantitative scoring, point-lesion counting (using a grid)
to computer-assisted methods. This was the first study
to demonstrate strong correlation of different cardiacfibrosis scoring methods, however, due to considerable
input by the investigator in computer analysis it still can
be considered as subjective to some degree. Particularly
since a stereology test grid was not used for RVS. Hadi
et al. [16] quantified cardiac fibrosis by automated ana-
lysis using ImageJ software and traditional polarization
microscopy, with subsequent validation of the results,
using stereology data as criterion standard. To our
knowledge, it is the only study of cardiac fibrosis that
applied stereology procedures to obtain RVS; however,
the validation was performed on rat cardiac rather than
human samples (the analysis was then tested on a post-
mortem tissue samples from a 78 year old man).
In our study, we have tested several methods to evalu-
ate the extent of human cardiac fibrosis, which can be
AB
C
Figure 6 Bland-Altman plots and histograms of the method score differences: (A) colocalization and stereology; (B) genie and
stereology; (C) pathologist mean score and stereology. Horizontal line represents mean difference within limits of agreement, which are
defined as the mean difference ± 2 standard deviations.
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stereology as the most independent and objective RVS
available and a modified Bland-Altman plot as the best
statistical tool to measure agreement between the tested
method and a RVS.
The initial data were somewhat in favor of the Colocali-
zation software: it demonstrated the closest fibrosis mean
value to a reference and resulting difference of 0.50% was
statistically insignificant. However, the Colocalization soft-
ware had a noticeably narrower variation, which was 20%
behind the RVS and the pathologist’s range, and also 15%
behind the Genie software. This drawback may be not of
great importance in clinical practice, as the range limita-
tion was only evident in the higher range and myocardium
fibrosis hardly reaches these values, whereas the lowerrange was acceptable. Further analysis revealed the super-
iority of Genie software: the higher correlation with RVS,
the better values in single linear regression against the ref-
erence and, most importantly, more uniform results in
Bland Altman analysis. While the Colocalization software
was overestimating at the lower end and underestimating
at the higher end, Genie software was only slightly under-
estimating in a mid-range with the results still exceeding
those of the pathologist’s mean score. Of note, both digital
algorithms produced slightly different results, a fact that
might appear surprising. Despite both algorithms are
aimed to measure the same feature, namely, the propor-
tion of connective tissue in the myocardium, they are still
based on different principles and may result in different
measurement errors. While Colocalization classifies each
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ware is based on a far more complex pattern recognition
system, which also refers to spatial aspects of the image.
Probably, the only relevant drawback of Genie was the
underestimation bias of 1.61% from the RVS. Overall, the
Genie classifier performed best in our study, being closest
to the RVS, with almost perfect correlation, adequate
range and uniform results throughout the whole scale.
Potential limitations of the Genie software are related
to the necessity to train the system to identify the vari-
ous structures of interest, which is time-consuming
and based on the inherent subjectivity of the “human
trainer”. This fact also makes the Genie software sensi-
tive to inter-laboratory reproducibility issues. However,
after the adaptation of Genie software to the clinical
needs it can be run fully automated and as a result it
can be equally as time-efficient as the Colocalization
software is. The Genie software has the possibility of
tuning the algorithm, which makes it more flexible in
practical maintenance. Even if 2% is an acceptable error
for cardiac fibrosis estimate in clinical sense, this algorithm
may require further adaptation to potential sources of slide
quality variation.
The Colocalization software has also proved to be a
fully acceptable method for cardiac fibrosis measure-
ment. In clinical practice, the Colocalization software
should provide similar precision and accuracy as the
Genie tool, because cardiac fibrosis values are rarely ex-
ceeding 40%, and a slight overestimation in the lower
range may be acceptable. The Colocalization software is
less complex, simpler to use and calibrate, and less ex-
pensive. Furthermore it can be run fully automated from
image scanning to the final results and it is very time ef-
ficient. The Colocalization algorithm is less dependent
on human investigator input at any point of the process
(except initial settings for color deconvolution), making
it more transparent and manageable for users.
Conclusions
Both digital image analysis methods based on colocaliza-
tion and pattern recognition algorithms revealed almost
perfect correlation with the criterion standard obtained
by stereology grid count and, in terms of accuracy, out-
performed the pathologist’s visual score. The Genie algo-
rithm proved to be the method of choice with the single
drawback of a slight underestimation bias that can be
acceptable for clinical and research demands to quantify
the extent of fibrosis in myocardial biopsies.
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